Physician

Sibyl Wray, MD

According to 2025 Medicare claims, Sibyl Wray, MD (NPI: 1881662591) practices neurology in the Knoxville, TN market, with the plurality of this provider's patient population coming from Knox, TN. This provider's primary affiliated billing organization is SIBYL WRAY MD NEUROLOGY PC (NPI: 1154522449; TIN: 77-0594363) and primary practice location at 37922-6591.

Wray's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 218 traditional Medicare patients, billed 41,431 HCPCS/CPT codes, and received $1,252,385 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 2,776 prescription claims across 233 beneficiaries totaling $4,029,952 in drug costs, led by Ocrevus (Ocrelizumab). DME data shows 13 claims. Open Payments data shows 556 records totaling $4,241,469. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $235,690 to $1,252,385. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $4,097 and ending at $3,032.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	220	21,121	$235,690
2016	224	8,169	$235,877
2017	210	4,043	$75,507
2018	225	3,718	$75,018
2019	203	4,939	$98,587
2020	195	3,176	$57,424
2021	172	2,344	$43,013
2022	178	28,171	$946,398
2023	210	36,923	$1,208,212
2024	218	41,431	$1,252,385

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	222	3,410	$4,403,957
2016	249	4,106	$5,918,132
2017	257	3,596	$6,439,862
2018	267	4,179	$6,102,068
2019	283	5,142	$6,430,748
2020	298	6,195	$7,493,029
2021	287	5,958	$7,421,353
2022	271	4,978	$5,769,822
2023	239	3,305	$4,597,424
2024	233	2,776	$4,029,952

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	22	$815
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	22	$769
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	13	$2,924

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	78	91	$118
96413	Administration of chemotherapy into vein, 1 hour or less	52	157	$75
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	167	235	$72
96365	Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less	49	72	$38
96127	Assessment of emotional or behavioral problems	101	171	$0

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ocrevus	Ocrelizumab	15	2,430	$551,860
Kesimpta Pen	Ofatumumab	62	1,790	$550,070
Aubagio	Teriflunomide	55	1,650	$511,140
Vumerity	Diroximel Fumarate	52	1,680	$487,871
Tecfidera	Dimethyl Fumarate	24	720	$229,386

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	N/R	13	$2,924

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	107	$28,322	Biogen, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	449	$4,213,147	Novartis Pharmaceuticals Corporation
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Sibyl Wray, MD?

Tedicare shows public-source Medicare data for Sibyl Wray, MD (NPI 1881662591), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Sibyl Wray, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Sibyl Wray, MD?

Sibyl Wray, MD is linked to SIBYL WRAY MD NEUROLOGY PC (billing NPI 1154522449) in the available physician profile data.

Does Sibyl Wray, MD have Open Payments data?

Sibyl Wray, MD has 556 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.